Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases

30Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are a heterogeneous group of debilitating disorders with multifactorial etiologies and pathogeneses that manifest distinct molecular mechanisms and clinical manifestations with abnormal protein dynamics and impaired bioenergetics. Mitochondrial dysfunction is emerging as an important feature in the etiopathogenesis of these age-related neurodegenerative diseases. The prevalence and incidence of these diseases is on the rise with the increasing global population and average lifespan. Although many therapeutic approaches have been tested, there are currently no effective treatment routes for the prevention or cure of these diseases. We present the current status of our knowledge and understanding of the involvement of mitochondrial dysfunction in these diseases and highlight recent advances in novel therapeutic strategies targeting neuronal bioenergetics as potential approach for treating these diseases.

Cite

CITATION STYLE

APA

Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021, August 1). Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases. Neural Regeneration Research. Wolters Kluwer Medknow Publications. https://doi.org/10.4103/1673-5374.303007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free